Gilead Sciences, Inc. (GILD) Stock Overview
Explore Gilead Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Gilead Sciences, Inc. (GILD)
Key Financials
Key Financials
Market Cap
181.4B
P/E Ratio
-56.46
EPS (TTM)
$-0.39
ROE
-0.16%
GILD Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Gilead Sciences, Inc. (NASDAQ: GILD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Gilead Sciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of GILD on the NASDAQ shows an RSI of 67.69, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $159.36 for the NASDAQ listing.
Key metrics behind Gilead Sciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -56.46 and a market capitalization of 181.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GILD on the NASDAQ.